Obstetrics and Gynecology

1046 soru

Soru 661Soru →

Match each normal obstetrical finding or clinical milestone to the earliest gestational age at which it is typically expected during a normal, uncomplicated pregnancy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Transvaginal ultrasound visualization of a gestational sac containing a yolk sac
Fetal heart tones become reliably audible via a handheld Doppler device
Uterine fundus becomes palpable midway between the pubic symphysis and the maternal umbilicus
Uterine fundus becomes palpable precisely at the level of the maternal umbilicus

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Yolk sac on transvaginal ultrasound: 5 to 6 weeks. Fetal heart tones via Doppler: 10 to 12 weeks. Fundus midway to umbilicus: 16 weeks. Fundus at umbilicus: 20 weeks.
In a normal pregnancy, clinical dating utilizes well-established milestones. A gestational sac containing a yolk sac is the earliest definitive sonographic evidence of an intrauterine pregnancy, reliably visible via transvaginal ultrasound at 5 to 6 weeks gestation. By 10 to 12 weeks, the uterus begins to rise out of the protective bony pelvis, which allows fetal heart tones to be auscultated externally with a handheld Doppler device. Physical examination of uterine growth follows a predictable pattern: by 12 weeks, the fundus is palpable at the pubic symphysis; by 16 weeks, it is palpable midway between the pubic symphysis and the maternal umbilicus; and by 20 weeks, it reaches the level of the umbilicus.

Adım Adım Çözüm

1
Identify the timeline for early sonographic landmarks.
The yolk sac appears within the gestational sac at 5 to 6 weeks gestation.
This early sonographic finding confirms an intrauterine pregnancy before physical examination changes are prominent.
2
Determine the timeline for clinical auscultation of fetal heart tones.
A handheld Doppler can reliably detect fetal heart tones by 10 to 12 weeks gestation.
The uterus must grow enough to become an abdominal organ (rising above the pelvic brim) to allow the Doppler signal to easily penetrate the maternal abdomen.
3
Track second-trimester anatomical fundal height progression.
The fundus reaches midway between the symphysis pubis and umbilicus at 16 weeks, and reaches the umbilicus at 20 weeks.
Uterine growth follows a highly predictable anatomical trajectory in the second trimester, serving as a reliable bedside marker for appropriate fetal growth.

Anahtar Kavram

Normal obstetrical milestones and gestational dating landmarks
Soru 662Soru →

A 39-year-old nulligravid female presents to the physician reporting eight months of heavy, unpredictable vaginal bleeding. Her menstrual cycles were previously regular, occurring every 2828 to 3030 days and lasting 55 days. Over the past eight months, bleeding episodes have occurred at irregular intervals ranging from 1515 to 4545 days, with menses lasting up to 1010 days and requiring her to change super-absorbency pads every two hours on heavy days. Medical history is significant for type 2 diabetes mellitus, chronic hypertension, and morbid obesity. Current medications include metformin and lisinopril. Vital signs show a temperature of 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure of 148/92 mm Hg148/92\text{ mm Hg}, pulse of 82/min82/\text{min}, and a body mass index (BMI) of 42 kg/m242\text{ kg/m}^2. Pelvic examination reveals normal external genitalia, a normal-appearing cervix, and a bulky but non-tender uterus. A urine pregnancy test is negative. Laboratory studies show a hemoglobin level of 10.2 g/dL10.2\text{ g/dL}. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Endometrial biopsy

Cevap

Endometrial biopsy
The correct answer is endometrial biopsy. The patient is presenting with abnormal uterine bleeding (AUB). While endometrial biopsy is universally indicated for AUB in patients aged 4545 years and older, it is also strictly indicated in patients under 4545 years of age who possess risk factors for endometrial hyperplasia and carcinoma. These risk factors include chronic unopposed estrogen exposure (typically due to obesity or polycystic ovary syndrome), nulliparity, type 2 diabetes mellitus, and a family history of Lynch syndrome. This patient's morbid obesity (BMI 42 kg/m242\text{ kg/m}^2) results in excess peripheral aromatization of androgens to estrone, creating an environment of continuous, unopposed estrogen that thickens the endometrium and dramatically increases her risk for malignancy. A tissue diagnosis must be secured before any medical therapy is initiated.

Adım Adım Çözüm

1
Analyze the patient's primary presentation.
The patient is a 39-year-old female presenting with abnormal uterine bleeding (AUB) characterized by irregular, heavy, and prolonged menses for 8 months.
Establishing the pattern of bleeding helps categorize it within the PALM-COEIN framework and guides the urgency of ruling out malignancy.
2
Identify patient-specific risk factors for endometrial pathology.
The patient has a BMI of 42 kg/m², type 2 diabetes, and nulliparity.
Obesity causes increased peripheral conversion of androgens to estrone by adipose tissue aromatase, leading to chronic unopposed estrogen exposure, which drives endometrial hyperplasia.
3
Apply clinical guidelines for AUB evaluation.
Guidelines dictate that endometrial biopsy is indicated for AUB in any patient aged ≥45\ge 45 years, OR in patients <45< 45 years if they have risk factors for endometrial hyperplasia/cancer (e.g., obesity, PCOS, failed medical management).
Since this patient is 39 but has profound risk factors (obesity, diabetes, nulliparity), she meets the criteria for immediate tissue sampling to rule out malignancy before initiating symptom-directed therapy.

Anahtar Kavram

In premenopausal women presenting with abnormal uterine bleeding, an endometrial biopsy is mandatory if the patient has risk factors for unopposed estrogen exposure (such as obesity, chronic anovulation, or diabetes) regardless of age being less than 45.

Alternatif Yöntem

When approaching AUB questions, immediately check the patient's age and BMI. If age is >= 45, select biopsy. If age is < 45 but BMI is > 30 or the patient has PCOS, also select biopsy.
Tahmini Süre:1m 30s
Soru 663Soru →

An established 3434-year-old patient presents to the gynecology clinic reporting relentless vulvovaginal pruritus and burning that has persisted for the past month. She states that a three-dose course of oral fluconazole prescribed four weeks ago provided almost no symptom relief. Her past medical history is notable for poorly controlled type 2 diabetes mellitus with a recent hemoglobin A1c of 9.2%9.2\%. On speculum examination, the vulvar and vaginal mucosae are intensely erythematous, and there is a thick, white, clumpy discharge adherent to the vaginal sidewalls. Vaginal fluid pH is 4.24.2. Microscopic evaluation of the discharge prepared with 10%10\% potassium hydroxide reveals numerous budding yeast cells, but a complete absence of pseudohyphae or true hyphae. Which of the following is the most appropriate pharmacotherapy for this patient's condition?

Cevabı ve açıklamayı göster

Cevap: Intravaginal boric acid

Cevap

Intravaginal boric acid
This patient's clinical presentation of fluconazole-refractory vulvovaginitis, combined with a potassium hydroxide (10%10\% KOH) preparation demonstrating budding yeast without pseudohyphae, strongly indicates a non-albicans Candida infection. The most common culprit is Candida glabrata. Unlike Candida albicans, which is dimorphic and readily forms both budding yeast cells and pseudohyphae, Candida glabrata exists solely in the budding yeast form. Furthermore, C. glabrata is intrinsically resistant to standard azole antifungal medications (like fluconazole). Poorly controlled diabetes is a classic risk factor for these atypical, resistant fungal infections. The most appropriate first-line pharmacotherapy for symptomatic, azole-refractory C. glabrata vulvovaginitis is intravaginal boric acid (typically 600 mg600\text{ mg} daily for 1414 days).

Adım Adım Çözüm

1
Analyze the patient's symptoms and medication history.
The patient has persistent vulvovaginitis that failed to improve with a standard three-dose regimen of oral fluconazole.
Treatment failure with a systemic azole raises suspicion for a non-albicans Candida species, which are inherently resistant to standard azole therapy.
2
Interpret the objective examination and laboratory findings.
Vaginal pH is normal (4.24.2), and the KOH prep shows budding yeast but strictly no pseudohyphae.
A normal pH confirms a fungal etiology (ruling out BV and Trichomonas). The strict absence of pseudohyphae differentiates Candida glabrata from Candida albicans (which typically forms both budding yeast and pseudohyphae).
3
Select the appropriate targeted pharmacotherapy.
Intravaginal boric acid is selected.
Candida glabrata is the most common non-albicans cause of vulvovaginal candidiasis and is highly resistant to fluconazole. The first-line treatment for this specific pathogen is intravaginal boric acid for 1414 days.

Anahtar Kavram

Diagnosis and management of non-albicans vulvovaginal candidiasis (Candida glabrata)
Tahmini Süre:1m 15s
Soru 664Soru →

A 29-year-old G1P0 at 39 weeks gestation undergoes an emergent cesarean delivery. She presented to the labor triage unit 20 minutes prior with painful uterine contractions and a history of a sudden gush of fluid at home. Upon admission, her cervix was 6 cm dilated, and the fetal heart rate was found to be persistently in the 60s, prompting immediate surgical intervention. A male neonate is delivered and requires positive pressure ventilation.

Umbilical artery blood gas analysis is obtained immediately after delivery:

ParameterValueReference Range
pHpH6.966.967.20−7.307.20 - 7.30
pCO2pCO_28888 mm Hg40−5040 - 50 mm Hg
pO2pO_21414 mm Hg15−2515 - 25 mm Hg
Bicarbonate2121 mEq/L20−2420 - 24 mEq/L
Base excess−4-4 mEq/L>−12> -12 mEq/L

Which of the following is the most likely primary mechanism for this neonate's acid-base derangement?

Cevabı ve açıklamayı göster

Cevap: Acute occlusion of umbilical cord vessels

Cevap

Acute occlusion of umbilical cord vessels
The correct answer identifies that the neonate is suffering from a pure, acute respiratory acidosis. Because CO2CO_2 is highly lipid-soluble, it diffuses across the placenta extremely rapidly under normal conditions. Any abrupt cessation of umbilical blood flow—such as acute occlusion of umbilical cord vessels following a cord prolapse—causes an immediate spike in fetal pCO2pCO_2 and a corresponding drop in pHpH. Because the hypoxic event in this scenario occurred so acutely (within 20 minutes prior to delivery), there was inadequate time for fetal tissues to transition to anaerobic glycolysis and accumulate lactic acid. As a result, the base excess remains normal.

Adım Adım Çözüm

1
Analyze the umbilical artery blood gas parameters.
The pHpH is 6.966.96 (severe acidemia), pCO2pCO_2 is markedly elevated at 8888 mm Hg (hypercapnia), while both bicarbonate (2121 mEq/L) and base excess (−4-4 mEq/L) remain within normal limits.
To identify the primary nature of the acid-base derangement.
2
Classify the type of fetal acidemia.
The presence of severe hypercapnia with a normal base excess (no base deficit) defines an uncompensated, isolated acute respiratory acidosis.
To differentiate between an acute event (no time for lactic acid accumulation) and a prolonged event (which would cause a metabolic lactic acidosis).
3
Correlate the acid-base diagnosis with the clinical scenario.
An acute respiratory acidosis corresponds to a sudden, catastrophic interruption of umbilical blood flow that rapidly halts CO2CO_2 clearance. The sudden gush of fluid followed by profound fetal bradycardia points directly to umbilical cord prolapse.
To connect the pathophysiologic mechanism to the correct answer choice.

Anahtar Kavram

Fetal umbilical cord blood gas analysis can differentiate acute intrapartum events from chronic hypoxic stress. An isolated acute respiratory acidosis (low pH, high pCO2, normal base excess) indicates a sudden interruption of umbilical blood flow, such as umbilical cord prolapse.
Tahmini Süre:2m 0s
Soru 665Soru →

A 30-year-old nulliparous woman presents to the clinic for preconception counseling. She plans to discontinue her oral contraceptives and attempt pregnancy in the coming months. The patient is highly detail-oriented and requests a comprehensive timeline of the routine medical evaluations she should expect once she conceives. The physician explains the standard sequence of prenatal care milestones. Assuming she achieves an uncomplicated, spontaneous singleton pregnancy and establishes care early in the first trimester, arrange the following routine prenatal screening evaluations in the correct chronological order from earliest to latest in gestation.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: first-trimester combined screening (10-14 weeks), followed by MSAFP screening (15-18 weeks), fetal anatomy ultrasound (18-22 weeks), gestational diabetes screening (24-28 weeks), and finally Group B Streptococcus screening (36-38 weeks).
Routine prenatal care is structured around specific gestational age windows to maximize the diagnostic yield of each test. First, first-trimester combined screening (nuchal translucency, PAPP-A, beta-hCG) is performed between 10 0/7 and 13 6/7 weeks. Second, MSAFP screening for neural tube defects is optimal at 15 to 18 weeks (though acceptable up to 22 weeks). Third, the detailed fetal anatomy ultrasound is performed at 18 to 22 weeks when fetal structures are adequately developed for rigorous sonographic evaluation. Fourth, gestational diabetes screening occurs at 24 to 28 weeks, coinciding with the peak placental production of anti-insulin hormones. Finally, Group B Streptococcus (GBS) screening via rectovaginal swab is performed at 36 0/7 to 37 6/7 weeks, close to the time of delivery, to accurately predict intrapartum colonization status and the need for antibiotic prophylaxis.

Adım Adım Çözüm

1
Identify the screening modality described by 'Ultrasound evaluation of the posterior fetal neck combined with maternal serum biomarkers'.
This refers to the first-trimester combined screening (nuchal translucency), performed early at 10 to 14 weeks.
This is the earliest routine screening test for aneuploidy.
2
Identify the screening modality described by 'Maternal serum testing for biomarkers associated with open neural tube and abdominal wall defects'.
This refers to the maternal serum alpha-fetoprotein (MSAFP) test or quadruple screen, optimally performed at 15 to 18 weeks.
MSAFP is used to screen for neural tube defects in the early second trimester.
3
Identify the screening modality described by 'Comprehensive sonographic assessment of fetal organ development and placental location'.
This refers to the fetal anatomy ultrasound, performed at 18 to 22 weeks.
This mid-second-trimester ultrasound is standard for evaluating fetal structures and placental position.
4
Identify the screening modality described by 'Universal maternal screening for impaired glucose tolerance'.
This refers to the gestational diabetes screening (1-hour glucose challenge test), performed at 24 to 28 weeks.
Insulin resistance peaks in the late second and third trimesters due to placental hormones, making this the optimal screening window.
5
Identify the screening modality described by 'Assessment for maternal rectovaginal bacterial colonization'.
This refers to the Group B Streptococcus (GBS) swab, performed at 36 to 38 weeks.
This is performed late in the third trimester to guide intrapartum antibiotic prophylaxis and prevent early-onset neonatal sepsis.

Anahtar Kavram

Routine prenatal care follows a standardized chronological schedule for screening fetal and maternal health, progressing from aneuploidy and anatomical screening in the first and second trimesters to maternal medical conditions (GDM) and peripartum infectious risks (GBS) in the late second and third trimesters.
Soru 666Soru →

A 2929-year-old woman, G1P1, is evaluated on postpartum day 33 for a new-onset fever, chills, and lower abdominal pain. Three days ago, she underwent a primary low transverse cesarean delivery due to active phase arrest. Her membranes had been ruptured for 2222 hours prior to delivery. Her temperature is 39.0∘C39.0^\circ\text{C} (102.2∘F102.2^\circ\text{F}), blood pressure is 112/72 mmHg112/72\text{ mmHg}, pulse is 112/min112/\text{min}, and respirations are 18/min18/\text{min}. Physical examination reveals soft, non-tender breasts without erythema. Her abdomen is soft. The cesarean incision is clean, dry, and intact, with no erythema, induration, or purulent drainage. Palpation of the uterine fundus elicits severe tenderness. Pelvic examination reveals a normal-appearing cervix with moderate, foul-smelling lochia. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Intravenous clindamycin and gentamicin

Cevap

Intravenous clindamycin and gentamicin
This patient's clinical presentation of fever, uterine tenderness, and foul-smelling lochia on postpartum day 33 following a cesarean delivery is classic for postpartum endometritis. The primary risk factor is the cesarean delivery itself, compounded by her prolonged rupture of membranes and arrest of labor. The infection is typically polymicrobial, involving both aerobes and anaerobes. The gold-standard treatment for post-cesarean endometritis is broad-spectrum intravenous antibiotic therapy with clindamycin (covering anaerobes and Gram-positive cocci) and gentamicin (covering Gram-negative bacilli). Treatment is continued until the patient has been afebrile for 2424 to 4848 hours.

Adım Adım Çözüm

1
Analyze the clinical presentation.
The patient is on postpartum day 3 after a cesarean delivery (with prolonged rupture of membranes) and presents with high fever, marked uterine tenderness, and foul-smelling lochia.
Identifying the timing of the fever and localizing signs is crucial for diagnosing the source of postpartum fever.
2
Determine the diagnosis.
The combination of fever, uterine fundal tenderness, and purulent lochia establishes the clinical diagnosis of postpartum endometritis.
Cesarean delivery, especially after prolonged membrane rupture and labor, is the most significant risk factor for polymicrobial endometritis.
3
Select the appropriate management.
Initiate empiric intravenous clindamycin and gentamicin.
Post-cesarean endometritis requires broad-spectrum coverage, including against anaerobes (e.g., Bacteroides species), which is provided by clindamycin, while gentamicin covers Gram-negative aerobes.

Anahtar Kavram

Postpartum endometritis is the most common cause of puerperal fever, presenting with uterine tenderness and foul lochia. It is treated with intravenous clindamycin and gentamicin.
Soru 667Soru →

A 22-year-old woman presents to the outpatient clinic reporting a 5-day history of yellowish vaginal discharge and spotting after intercourse. Her last menstrual period was 6 weeks ago, and she reports inconsistent condom use with a new male partner. Her temperature is 37.2°C (99.0°F), blood pressure is 110/70 mm Hg, and pulse is 82/min. Speculum examination reveals a friable cervix with mucopurulent exudate. Bimanual examination demonstrates mild cervical motion tenderness without uterine or adnexal tenderness. Arrange the following steps in the most appropriate chronological sequence for the clinical and public health management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of steps is to first perform a pregnancy test, followed by obtaining NAAT swabs, administering empiric antibiotics, ensuring partner treatment, and finally scheduling a 3-month follow-up for repeat testing.
The management of suspected cervicitis or early pelvic inflammatory disease follows a strict clinical workflow. First, because the patient is a reproductive-age female with delayed menses who will likely need doxycycline (a known teratogen), a pregnancy test is strictly required. Second, to accurately identify the causative organism, diagnostic NAAT swabs must be obtained before introducing any antibiotics. Third, because delaying treatment increases the risk of tubo-ovarian abscess, ectopic pregnancy, and infertility, empiric therapy (ceftriaxone and doxycycline) is administered immediately. Fourth, public health protocols require treating the partner to break the chain of transmission. Finally, because reinfection rates are high, standard guidelines require repeat screening at 3 months.

Adım Adım Çözüm

1
Rule out pregnancy
A point-of-care urine pregnancy test is performed.
The patient has 6 weeks of amenorrhea and requires a treatment regimen that includes doxycycline, which is contraindicated in pregnancy. Establishing pregnancy status dictates the safe choice of antibiotics.
2
Collect diagnostic specimens
Vaginal or cervical swabs are collected for nucleic acid amplification testing (NAAT).
Specimens must be obtained before antimicrobial therapy is administered to prevent false-negative diagnostic results and ensure accurate epidemiological tracking.
3
Initiate empiric antimicrobial therapy
Intramuscular ceftriaxone and oral doxycycline are administered.
The patient has clinical signs of cervicitis and early pelvic inflammatory disease. Empiric treatment should not be delayed while waiting for NAAT results in order to prevent severe reproductive sequelae.
4
Address community transmission and reinfection risk
Expedited partner therapy (EPT) or counseling is provided.
Treating the patient's sexual contacts immediately following the patient's treatment is the most effective public health strategy to break the chain of transmission and prevent reinfection.
5
Monitor for reinfection
A 3-month follow-up visit is scheduled.
Guidelines mandate repeat NAAT screening 3 months after treatment for chlamydia or gonorrhea due to the disproportionately high rates of reinfection in this demographic.

Anahtar Kavram

The chronological management of suspected cervicitis and early pelvic inflammatory disease prioritizes ruling out pregnancy, obtaining diagnostic swabs before antibiotic administration, administering empiric broad-spectrum antibiotics, treating sexual partners, and ensuring a 3-month test for reinfection.
Tahmini Süre:1m 30s
Soru 668Soru →

A 26-year-old primigravid patient at 40 weeks gestation is admitted to the labor and delivery unit in active spontaneous labor. Her prenatal course was uncomplicated. Spontaneous rupture of membranes occurred 4 hours ago, revealing thick meconium-stained amniotic fluid. Her temperature is 37.1°C (98.8°F), blood pressure is 118/76 mmHg, and pulse is 82/min.

Pelvic examination demonstrates the cervix is 6 cm dilated, 100% effaced, and the fetal vertex is at 0 station. No structures are palpable ahead of the presenting part.

Continuous external fetal monitoring over the last 30 minutes shows a baseline heart rate of 140/min and moderate variability. There are recurrent, abrupt decreases in the fetal heart rate to 80/min that last for 45 to 60 seconds before returning rapidly to baseline. These decreases do not have a consistent temporal relationship with the uterine contractions. The contractions are occurring every 3 to 4 minutes and last 60 seconds.

The nurse assists the patient into the left lateral, right lateral, and hands-and-knees positions, and administers a 500 mL intravenous bolus of lactated Ringer solution. Despite these resuscitative maneuvers, the fetal heart rate pattern remains unchanged for the next 20 minutes. A repeat cervical examination shows no change in dilation.

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Transcervical amnioinfusion to relieve umbilical cord compression

Cevap

The most appropriate next step is to perform a transcervical amnioinfusion to relieve umbilical cord compression.
The patient's fetal heart rate monitoring demonstrates recurrent variable decelerations, characterized by an abrupt decrease in the heart rate (onset to nadir in less than 30 seconds) that is visually unassociated with uterine contractions. Variable decelerations are caused by umbilical cord compression, which can be exacerbated by the loss of amniotic fluid following rupture of membranes. Initial management of recurrent variable decelerations includes maternal repositioning (to shift the fetus off the cord) and intravenous fluid hydration. When these initial resuscitative measures fail to resolve the decelerations, transcervical amnioinfusion (instillation of normal saline or lactated Ringer solution into the uterine cavity) is the next indicated step. Amnioinfusion artificially restores the amniotic fluid volume, providing a protective cushion around the umbilical cord and relieving the compression.

Adım Adım Çözüm

1
Analyze the fetal heart rate (FHR) tracing characteristics.
The FHR shows recurrent, abrupt decelerations that vary in timing relative to contractions, identifying them as variable decelerations.
Accurate identification of the deceleration type is essential to determine the underlying pathophysiology.
2
Determine the pathophysiology of the decelerations.
Variable decelerations are caused by umbilical cord compression, which is likely exacerbated in this patient by the spontaneous rupture of membranes and subsequent loss of amniotic fluid.
Understanding the cause directs the specific resuscitative intervention.
3
Evaluate the response to initial resuscitative measures.
Maternal repositioning and intravenous fluids failed to resolve the variable decelerations.
If initial measures fail, secondary interventions are required to prevent fetal acidemia.
4
Select the definitive secondary intervention.
Transcervical amnioinfusion is selected to artificially replace the lost amniotic fluid and cushion the umbilical cord.
Amnioinfusion directly addresses the pathophysiology of cord compression when positional changes are inadequate.

Anahtar Kavram

Recurrent variable decelerations are caused by umbilical cord compression and are managed with maternal repositioning followed by transcervical amnioinfusion if initial measures fail. Amnioinfusion is no longer indicated for the prophylactic dilution of meconium.
Tahmini Süre:1m 30s
Soru 669Soru →

Match each patient's clinical profile with the most appropriate contraceptive method based on the Medical Eligibility Criteria for Contraceptive Use.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 34-year-old woman with active breast cancer who desires a highly effective, long-acting reversible contraceptive method.
A 26-year-old woman with Wilson disease and a bicornuate uterus who desires a highly effective, long-acting reversible contraceptive method.
A 29-year-old woman with a history of unprovoked deep vein thrombosis and heavy menstrual bleeding causing symptomatic anemia.
A 23-year-old woman with sickle cell disease who desires a highly effective contraceptive method that may also decrease the frequency of her vaso-occlusive pain crises.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches depend on identifying absolute contraindications and secondary benefits. Active breast cancer requires the hormone-free copper intrauterine device. Wilson disease and a bicornuate uterus necessitate the subdermal etonogestrel implant to avoid copper toxicity and uterine placement. Deep vein thrombosis with heavy bleeding is best managed with the levonorgestrel-releasing intrauterine device. Sickle cell disease benefits uniquely from depot medroxyprogesterone acetate.
Each correct pairing navigates the Medical Eligibility Criteria by avoiding Category 4 conditions (e.g., placing hormones in breast cancer patients, placing any device in a distorted uterine cavity) while maximizing secondary benefits (e.g., treating heavy bleeding with a levonorgestrel device, preventing pain crises with depot injections).

Adım Adım Çözüm

1
Evaluate the 34-year-old patient with active breast cancer.
Identify that all hormonal methods (estrogen and progestin) are Category 4 (absolute contraindication), leaving the copper intrauterine device as the optimal choice.
Hormones can stimulate the growth of hormone-receptor-positive breast cancers.
2
Evaluate the 26-year-old patient with Wilson disease and a bicornuate uterus.
Rule out the copper intrauterine device (due to abnormal copper metabolism) and the levonorgestrel intrauterine device (due to uterine cavity distortion), leaving the subdermal implant.
Proper placement and efficacy of intrauterine devices require a normal uterine cavity, and avoiding systemic copper accumulation is critical in Wilson disease.
3
Evaluate the 29-year-old patient with deep vein thrombosis and heavy menstrual bleeding.
Rule out estrogen-containing methods due to thrombotic risk, and select the levonorgestrel intrauterine device to directly treat the heavy bleeding.
The levonorgestrel intrauterine device thins the endometrial lining, significantly reducing menstrual blood loss.
4
Evaluate the 23-year-old patient with sickle cell disease.
Select depot medroxyprogesterone acetate.
This injectable progestin has been shown to stabilize red blood cell membranes and induce amenorrhea, thereby reducing sickle cell pain crises.

Anahtar Kavram

Applying the Medical Eligibility Criteria for contraceptive use to navigate complex absolute contraindications (Category 4) and utilize non-contraceptive benefits.
Tahmini Süre:1m 30s
Soru 670Soru →

A 24-year-old primigravid woman at 39 weeks gestation is evaluated in the labor and delivery unit. She was admitted 22 hours ago in active labor, at which time spontaneous rupture of membranes occurred. Her current temperature is 39.2°C (102.6°F), blood pressure is 110/70 mmHg, and heart rate is 118/min. Physical examination reveals a diffusely tender uterine fundus. Pelvic examination shows the cervix is 6 cm dilated, 100% effaced, and the fetal vertex is at 0 station. Purulent fluid is noted in the vaginal vault. The fetal heart rate tracing demonstrates a baseline of 175/min with moderate variability and no decelerations. Maternal laboratory studies show a leukocyte count of 18,000/mm318,000/\text{mm}^3 and a hemoglobin of 10.4 g/dL10.4 \text{ g/dL}. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Administer broad-spectrum intravenous antibiotics and allow labor to progress

Cevap

The most appropriate next step is to administer broad-spectrum intravenous antibiotics and allow labor to progress.
The patient meets the clinical criteria for intraamniotic infection (chorioamnionitis), characterized by maternal fever, prolonged rupture of membranes, uterine tenderness, maternal leukocytosis, and fetal tachycardia. The standard of care is prompt administration of broad-spectrum intravenous antibiotics (typically ampicillin and gentamicin) and antipyretics to reduce maternal fever and improve fetal hemodynamics. Intraamniotic infection alone is not an indication for cesarean delivery; expectant management of labor or labor augmentation to achieve a vaginal delivery is the preferred approach, as it carries lower morbidity for the mother.

Adım Adım Çözüm

1
Diagnose the maternal condition based on clinical findings.
The patient has intraamniotic infection (chorioamnionitis).
Diagnosis is confirmed by maternal fever (>39.0°C) along with prolonged rupture of membranes, uterine fundal tenderness, purulent vaginal fluid, maternal leukocytosis, and fetal tachycardia.
2
Evaluate the fetal heart rate tracing for signs of acidemia or distress.
The tracing shows baseline tachycardia (175/min) with moderate variability and no decelerations.
Moderate variability indicates the absence of fetal acidemia. The tachycardia is a physiologic fetal response to maternal fever and infection, making this a Category II (indeterminate but reassuring) tracing.
3
Determine the necessity of surgical versus medical intervention.
The patient requires medical management without immediate surgical delivery.
Intraamniotic infection is treated with broad-spectrum antibiotics (e.g., ampicillin and gentamicin) and antipyretics. It is not an automatic indication for cesarean delivery; vaginal delivery should be allowed to progress unless standard obstetric indications arise.

Anahtar Kavram

Diagnosis and management of intraamniotic infection (chorioamnionitis) during labor.
Tahmini Süre:1m 30s
Soru 671Soru →

During a scheduled mid-trimester visit at 2020 weeks gestation, a 3232-year-old multigravida reports feeling generally well, with only mild fatigue and occasional urinary frequency. Her blood pressure is 115/75115/75 mmHg and pulse is 8282/min. Physical examination reveals a fundal height consistent with dates and normal fetal heart tones. Routine laboratory screening is performed with the following results:

Hemoglobin: 11.211.2 g/dL
Leukocyte count: 12,50012,500/mm 3^3
Serum creatinine: 1.11.1 mg/dL
Alkaline phosphatase: 195195 U/L
Urinalysis: Trace glucose, negative for protein and nitrites

Which of the following laboratory findings in this patient is abnormal and warrants further diagnostic evaluation?

Cevabı ve açıklamayı göster

Cevap: Serum creatinine of 1.11.1 mg/dL

Cevap

The serum creatinine of 1.11.1 mg/dL is abnormal in pregnancy and requires further evaluation.
During normal pregnancy, maternal renal blood flow and glomerular filtration rate (GFR) increase by approximately 40%40\% to 50%50\%. This physiological hyperfiltration leads to increased clearance of urea and creatinine, resulting in a decrease in baseline serum levels. Normal serum creatinine in pregnancy typically ranges from 0.40.4 to 0.80.8 mg/dL. Therefore, a serum creatinine of 1.11.1 mg/dL, although within normal limits for a non-pregnant adult, is relatively elevated in this context and indicates underlying renal impairment that requires further diagnostic workup.

Adım Adım Çözüm

1
Evaluate the hemoglobin level against pregnancy-specific reference ranges.
Hemoglobin of 11.211.2 g/dL is within the normal range for the second trimester (lower limit of normal is 10.510.5 g/dL).
Maternal plasma volume expansion exceeds red blood cell mass expansion, causing a physiological dilutional anemia.
2
Analyze the leukocyte count and alkaline phosphatase.
Both are physiologically elevated. WBC counts up to 15,00015,000/mm 3^3 and elevated alkaline phosphatase (from placental production) are normal.
Recognizing pregnancy-induced baseline shifts prevents unnecessary workups for infection or hepatobiliary disease.
3
Assess the renal parameters (serum creatinine and urinalysis).
Trace glycosuria is normal due to increased filtered load. However, the serum creatinine of 1.11.1 mg/dL is abnormally high.
Pregnancy induces a 40%40\% to 50%50\% increase in Glomerular Filtration Rate (GFR), which should lower normal serum creatinine levels to 0.40.4-0.80.8 mg/dL. A level of 1.11.1 mg/dL suggests intrinsic renal dysfunction.

Anahtar Kavram

Physiologic renal adaptations in pregnancy include an increased GFR, leading to decreased baseline serum creatinine.
Soru 672Soru →

A healthy pregnant patient at 2828 weeks of gestation comes to the obstetric clinic for a scheduled evaluation. She is 2424 years old and this is her first pregnancy. The patient mentions occasionally feeling as though she cannot take in a full breath, especially when resting. She confirms she has no chest pain, cough, or difficulty speaking in full sentences, and she continues to walk her dog daily without limitation. Vital signs reveal a heart rate of 8585/min, respiratory rate of 1616/min, blood pressure of 112/68112/68 mmHg, and an oxygen saturation of 99%99\% on room air. Pulmonary auscultation reveals clear breath sounds bilaterally. A comprehensive metabolic panel and arterial blood gas analysis are drawn as part of a voluntary physiologic study she enrolled in. Which of the following profiles most accurately reflects the expected acid-base status in this patient?

Cevabı ve açıklamayı göster

Cevap: pH 7.447.44; PaCO 2_2 2828 mmHg; HCO 3−_3^- 1919 mEq/L

Cevap

pH 7.447.44; PaCO 2_2 2828 mmHg; HCO 3−_3^- 1919 mEq/L
During a normal pregnancy, elevated levels of circulating progesterone directly stimulate the central respiratory center in the medulla. This stimulation leads to a substantial increase in tidal volume and overall minute ventilation, even though the respiratory rate typically remains within normal limits. Consequently, pregnant patients often experience a subjective sensation of breathlessness, known as physiologic dyspnea of pregnancy.

Because minute ventilation is increased, pregnant women normally 'blow off' more carbon dioxide, resulting in a primary respiratory alkalosis characterized by a decreased PaCO 2_2 (typically between 2727 and 3232 mmHg). In response, the kidneys initiate a compensatory metabolic acidosis by increasing the excretion of bicarbonate, leading to a decreased serum HCO 3−_3^- (typically between 1818 and 2222 mEq/L). The resulting arterial pH is slightly basic, usually ranging from 7.407.40 to 7.457.45. The profile demonstrating a pH of 7.447.44, a PaCO 2_2 of 2828 mmHg, and an HCO 3−_3^- of 1919 mEq/L perfectly matches this expected chronic compensated respiratory alkalosis.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The patient reports a sensation of incomplete breaths with normal vital signs, a normal respiratory rate, and clear lungs.
This presentation is consistent with the physiologic dyspnea of pregnancy, a normal finding.
2
Identify the primary mechanism of respiratory changes in pregnancy.
Elevated progesterone levels directly stimulate the medullary respiratory center, causing an increase in tidal volume and minute ventilation.
This physiological hyperventilation leads to an expected decrease in arterial PaCO2, creating a primary respiratory alkalosis.
3
Determine the body's compensatory response.
To maintain near-normal blood pH, the kidneys increase the excretion of bicarbonate (HCO3-).
This metabolic compensation lowers serum bicarbonate levels to balance the low PaCO2.
4
Select the laboratory profile that matches this physiology.
The expected profile must demonstrate a slightly alkalemic pH, decreased PaCO2, and decreased HCO3-.
Only the profile with pH 7.44, PaCO2 28 mmHg, and HCO3- 19 mEq/L fits chronic compensated respiratory alkalosis.

Anahtar Kavram

Normal pregnancy is characterized by a progesterone-mediated increase in minute ventilation, which results in a chronic, compensated respiratory alkalosis (decreased PaCO2, decreased HCO3-, and slightly elevated pH).
Tahmini Süre:1m 15s
Soru 673Soru →

A 24-year-old woman comes to the clinic for evaluation of a newly identified right breast lump. She first noticed the mass 2 weeks ago while showering. The patient is otherwise healthy, takes no medications, and has no family history of breast cancer. Her menstrual cycles are regular, and her last menstrual period was 3 weeks ago. Vital signs are normal. On physical examination, there is a 2-cm, firm, mobile, and non-tender mass in the upper outer quadrant of the right breast. There is no overlying skin dimpling, nipple retraction, or axillary lymphadenopathy. Which of the following is the most appropriate next step in management of this patient?

Cevabı ve açıklamayı göster

Cevap: Targeted ultrasound of the right breast

Cevap

Targeted ultrasound of the right breast
The correct answer is targeted ultrasound of the right breast. The evaluation of a newly discovered, palpable breast mass is heavily dependent on the patient's age. For women under the age of 30, targeted ultrasound is the initial diagnostic modality of choice. This is because younger women typically have dense, radiopaque breast tissue that significantly decreases the sensitivity of mammography. Ultrasound effectively penetrates dense tissue and can accurately differentiate between a simple fluid-filled cyst and a solid mass (such as a fibroadenoma or, rarely, a malignancy). If the ultrasound reveals a benign-appearing solid mass (e.g., well-circumscribed, hypoechoic), observation or a core needle biopsy may be the subsequent step depending on patient preference and specific imaging characteristics.

Adım Adım Çözüm

1
Identify the primary clinical problem and patient demographic.
The patient is a 24-year-old woman presenting with a new, palpable, firm, and mobile breast mass.
Patient age is the most critical factor in determining the initial imaging modality for a breast mass.
2
Apply the age-based diagnostic algorithm for palpable breast masses.
For women under 30 years of age, targeted ultrasound is the first-line imaging modality. For women 30 years and older, diagnostic mammography is the first-line test.
Younger women typically have dense breast tissue, which decreases the sensitivity of mammography. Ultrasound effectively differentiates between solid masses and simple cysts regardless of tissue density.
3
Determine the next best step for this specific patient.
Because the patient is 24 years old (under 30), a targeted ultrasound of the right breast is required.
Imaging must be obtained to properly characterize the lesion before considering any invasive procedure (like biopsy) or relying solely on reassurance.

Anahtar Kavram

In patients under the age of 30 who present with a new palpable breast mass, targeted ultrasound is the most appropriate initial diagnostic step.
Soru 674Soru →

A 2525-year-old primigravida at 4141 weeks gestation is admitted to the labor and delivery unit for induction of labor due to postterm pregnancy. A continuous intravenous oxytocin infusion is initiated. Her cervix is 5 cm5\text{ cm} dilated and 80%80\% effaced. Uterine contractions are occurring every 33 to 44 minutes. The fetal heart rate baseline is 135/min135/\text{min} with moderate variability. Over the past 3030 minutes, the fetal heart rate tracing demonstrates recurrent, symmetric decreases in the heart rate that begin after the peak of each contraction, reach their nadir after the contraction ends, and then gradually return to baseline. Maternal vital signs are temperature 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure 118/76 mmHg118/76\text{ mmHg}, and heart rate 84/min84/\text{min}. Laboratory studies show a leukocyte count of 14,500/mm314,500/\text{mm}^3 and hemoglobin of 10.8 g/dL10.8\text{ g/dL}. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Discontinuation of oxytocin infusion and maternal repositioning

Cevap

Discontinuation of oxytocin infusion and maternal repositioning
The patient's fetal heart rate tracing demonstrates late decelerations, which are defined as visually apparent, gradual decreases in the fetal heart rate where the nadir of the deceleration occurs after the peak of the uterine contraction. Recurrent late decelerations are a sign of uteroplacental insufficiency and transient fetal hypoxia. The most appropriate next step is to initiate intrauterine resuscitation to maximize placental perfusion and oxygen delivery to the fetus. Standard resuscitative measures include maternal repositioning (typically to the left lateral decubitus position to relieve aortocaval compression), discontinuation of uterotonic agents such as oxytocin, administration of an intravenous fluid bolus, and providing supplemental oxygen. Proceeding directly to operative delivery is not indicated unless these measures fail or if the tracing deteriorates (e.g., absent variability).

Adım Adım Çözüm

1
Analyze the fetal heart rate tracing described in the vignette.
The tracing shows symmetric decreases beginning after the contraction peak and returning to baseline after the contraction ends. These are late decelerations.
Accurate interpretation of fetal heart rate patterns is necessary to identify the underlying pathophysiology (in this case, uteroplacental insufficiency).
2
Determine the appropriate management for recurrent late decelerations.
The initial management involves intrauterine resuscitation to improve uteroplacental blood flow.
Interventions such as maternal repositioning (left lateral decubitus), stopping uterotonics (oxytocin), administering IV fluid boluses, and providing oxygen can correct transient hypoxia before resorting to operative delivery.
3
Evaluate the maternal vital signs and laboratory findings to rule out confounding complications.
The mild leukocytosis (14,500/mm314,500/\text{mm}^3) and mild anemia (10.8 g/dL10.8\text{ g/dL}) are noted to be normal physiologic changes of pregnancy.
This confirms that there is no indication for antibiotics or other interventions targeting a non-existent infection.

Anahtar Kavram

Recurrent late decelerations indicate uteroplacental insufficiency and should initially be managed with intrauterine resuscitation, including maternal repositioning and discontinuation of oxytocin.
Tahmini Süre:1m 30s
Soru 675Soru →

A physician is evaluating a 62-year-old patient who reports highly distressing urinary symptoms that have persisted for the past eight months. She states that she frequently experiences an abrupt, overwhelming need to urinate, which is often followed by a large volume of urine loss before she can reach the bathroom. These episodes occur 4 to 5 times daily. There is no history of leakage associated with physical exertion, sneezing, or coughing. Her medical history includes well-controlled hypertension, narrow-angle glaucoma, and severe chronic idiopathic constipation that requires daily osmotic laxatives. Pelvic examination reveals normal vaginal rugae without erythema or atrophy, and there is no evidence of pelvic organ prolapse. The cough stress test is negative. Postvoid residual volume is 25 mL. Urinalysis shows no abnormalities. The patient has diligently completed an 8-week behavioral therapy program, including timed voiding and pelvic floor muscle training, with minimal improvement. Which of the following pharmacologic mechanisms is most appropriate to target for symptom relief in this patient?

Cevabı ve açıklamayı göster

Cevap: Stimulation of beta-3 adrenergic receptors

Cevap

The most appropriate pharmacologic mechanism to target for this patient's urgency urinary incontinence is the stimulation of beta-3 adrenergic receptors.
This patient presents with urgency urinary incontinence (UUI) that has not responded to first-line conservative management, indicating the need for pharmacotherapy. The two primary classes of medications for UUI are antimuscarinics (which inhibit M3 receptors) and beta-3 adrenergic agonists (which stimulate beta-3 receptors). Because this patient has narrow-angle glaucoma and severe chronic constipation, antimuscarinics are strongly contraindicated as they can precipitate an acute angle-closure glaucoma crisis and further impair gastrointestinal motility. Therefore, stimulating beta-3 adrenergic receptors with a medication like mirabegron is the most appropriate next step. Beta-3 agonism promotes detrusor muscle relaxation during the storage phase of the micturition cycle, thereby increasing bladder capacity and reducing involuntary detrusor contractions without causing anticholinergic side effects.

Adım Adım Çözüm

1
Diagnose the type of urinary incontinence based on the clinical presentation.
The patient has urgency urinary incontinence (UUI), evidenced by an abrupt, overwhelming need to urinate followed by a large volume of urine loss, with normal postvoid residual and a negative cough stress test.
Accurate characterization of the incontinence dictates the therapeutic algorithm.
2
Determine the appropriate phase of management.
Pharmacotherapy is indicated.
The patient has already failed an adequate trial of first-line conservative management (behavioral therapy and pelvic floor muscle training).
3
Evaluate the patient's medical history for contraindications to standard pharmacotherapy.
The patient has narrow-angle glaucoma and severe chronic idiopathic constipation.
Antimuscarinic agents (the traditional first-line pharmacologic treatment for UUI) exhibit significant anticholinergic side effects. They are absolutely contraindicated in narrow-angle glaucoma due to the risk of precipitating an acute crisis, and highly unfavorable in severe constipation.
4
Select the optimal alternative medication and identify its mechanism of action.
A beta-3 adrenergic agonist (e.g., mirabegron) is selected, which acts by stimulating beta-3 adrenergic receptors.
Beta-3 agonists promote detrusor muscle relaxation during the storage phase, effectively treating UUI while completely avoiding anticholinergic adverse effects.

Anahtar Kavram

Management of urgency urinary incontinence requires individualizing pharmacotherapy based on patient comorbidities; beta-3 adrenergic agonists are the preferred agents for patients with contraindications to antimuscarinics, such as narrow-angle glaucoma or severe constipation.
Soru 676Soru →

A 65-year-old G3P3 patient is evaluated in the urogynecology clinic prior to a scheduled surgical procedure. She has a symptomatic, advanced anterior vaginal wall prolapse that causes daily pelvic pressure and a bothersome vaginal bulge. The patient explicitly denies any current involuntary loss of urine, urinary urgency, or dysuria, stating that her bladder control is completely normal. Her medical history includes obesity, well-controlled hypertension, and a total abdominal hysterectomy for benign fibroids 12 years ago. Pelvic examination confirms a large cystocele protruding 4 cm beyond the hymenal ring during a Valsalva maneuver. The posterior vaginal wall and vaginal apex are well supported. Urinalysis is unremarkable, and postvoid residual volume is 25 mL. The patient is scheduled to undergo an anterior colporrhaphy next week. To prevent a common postoperative complication, which of the following is the most appropriate next diagnostic step to guide this patient's surgical plan?

Cevabı ve açıklamayı göster

Cevap: Cough stress test with the prolapse reduced

Cevap

The most appropriate next diagnostic step is a cough stress test with the prolapse reduced.
This patient has severe anterior pelvic organ prolapse (cystocele) without subjective symptoms of stress urinary incontinence. Severe prolapse can create a physical kink in the urethra that artificially increases outflow resistance, thereby preventing urine leakage during episodes of increased intra-abdominal pressure. This phenomenon masks underlying sphincter dysfunction, a condition known as "occult stress urinary incontinence (SUI)." Repairing the prolapse without addressing the occult SUI will straighten the urethra and potentially result in severe de novo stress incontinence postoperatively. Therefore, patients with advanced prolapse should undergo a cough stress test while the clinician manually reduces the prolapse (using a pessary, large swabs, or a speculum). If leakage is demonstrated, the patient is diagnosed with occult SUI and should be offered a concurrent anti-incontinence procedure (e.g., midurethral sling) at the time of the prolapse repair.

Adım Adım Çözüm

1
Identify the primary clinical scenario.
A patient with severe anterior pelvic organ prolapse (cystocele) without subjective symptoms of urinary incontinence is scheduled for an anatomical surgical repair.
Establishing the baseline anatomy and planned intervention is necessary to anticipate physiological changes.
2
Recognize the physiological impact of the anatomical defect.
Severe anterior vaginal wall prolapse can cause physical kinking of the urethra. This artificially increases urethral outflow resistance, which masks underlying sphincter weakness.
Understanding urethral kinking explains why a patient with sphincter deficiency might not experience incontinence while the prolapse is present.
3
Anticipate the consequences of the planned surgical intervention.
Anterior colporrhaphy will correct the prolapse and unkink the urethra. If the patient has underlying sphincter weakness, she will develop de novo stress incontinence immediately after recovering from surgery.
Preventing postoperative morbidity requires diagnosing "occult" stress urinary incontinence beforehand.
4
Determine the appropriate preoperative evaluation.
The clinician must temporarily simulate the postoperative state by manually reducing the prolapse (using a pessary, swabs, or speculum) and then performing a cough stress test.
If leakage occurs during this test, occult stress urinary incontinence is confirmed, and a concurrent anti-incontinence procedure (e.g., midurethral sling) should be offered.

Anahtar Kavram

Patients with severe pelvic organ prolapse but no symptoms of stress urinary incontinence must be evaluated for occult stress urinary incontinence by performing a cough stress test with the prolapse reduced.
Soru 677Soru →

A 31-year-old G3P3 woman experiences massive postpartum hemorrhage immediately following a spontaneous vaginal delivery of a 4200g neonate. Physical examination reveals a soft, enlarged, and boggy uterus. Initial management with continuous bimanual uterine massage, aggressive intravenous fluid resuscitation, and high-dose intravenous oxytocin has failed to arrest the bleeding. Her past medical history is significant for chronic hypertension and poorly controlled asthma. Arrange the following interventions in the most appropriate stepwise order of escalation for managing this patient's ongoing hemorrhage.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of escalation is: Administration of rectal misoprostol, followed by Insertion of an intrauterine balloon tamponade, then Exploratory laparotomy with placement of uterine compression sutures, and finally Total abdominal hysterectomy.
The management of uterine atony follows a stepwise escalation to minimize morbidity while controlling life-threatening hemorrhage. After initial massage and oxytocin fail, second-line uterotonics are given. In this patient, misoprostol is the only safe option due to contraindications to carboprost (asthma) and methylergonovine (hypertension). If medical management fails, mechanical tamponade (intrauterine balloon) is the next least invasive step. If bleeding persists, laparotomy is required, where fertility-sparing measures like uterine compression sutures (B-Lynch) are attempted first. Total abdominal hysterectomy is the definitive, final step when all other conservative measures fail.

Adım Adım Çözüm

1
Identify the cause of postpartum hemorrhage.
The patient has uterine atony, indicated by a soft, boggy uterus.
Establishing the etiology of postpartum hemorrhage dictates the specific management algorithm.
2
Select the appropriate second-line uterotonic agent.
Misoprostol is chosen.
The patient's asthma contraindicates carboprost tromethamine, and her chronic hypertension contraindicates methylergonovine. Misoprostol is the remaining safe pharmacological option.
3
Determine the next step if pharmacological management fails.
Intrauterine balloon tamponade.
Minimally invasive mechanical approaches should be utilized before proceeding to morbid surgical interventions.
4
Determine the sequence of surgical escalation.
Uterine compression sutures, followed by hysterectomy if necessary.
Fertility-sparing surgery (e.g., B-Lynch sutures, uterine artery ligation) is preferred; hysterectomy is reserved as a definitive, life-saving final measure.

Anahtar Kavram

Stepwise algorithmic management of postpartum hemorrhage due to uterine atony
Soru 678Soru →

A 31-year-old woman, gravida 2 para 1, at 37 weeks and 4 days gestation, presents to the emergency department reporting unremitting lower back pain for the past three hours. She has not experienced any vaginal bleeding, leakage of fluid, or recent trauma. Her medical history is significant for chronic hypertension managed with oral labetalol. Vital signs are temperature 37.1°C, pulse 115/min, blood pressure 152/92 mm Hg, and respirations 18/min. Physical examination reveals a firm, tense uterus that is tender to deep palpation. There is no visible blood in the vaginal vault on speculum examination, and the cervix is closed. Continuous electronic fetal monitoring demonstrates a baseline heart rate of 165/min, absent baseline variability, and repetitive late decelerations. The tocodynamometer shows high-frequency, low-amplitude uterine contractions occurring every 1 to 2 minutes with an elevated resting tone. Initial laboratory studies show a hemoglobin of 10.4 g/dL, platelet count of 105,000/mm³, and fibrinogen of 190 mg/dL. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Proceed to immediate cesarean delivery

Cevap

The most appropriate next step in management is to proceed to immediate cesarean delivery.
Proceeding to immediate cesarean delivery is correct because the patient is experiencing a severe concealed placental abruption complicated by fetal distress and maternal coagulopathy. The presentation of unremitting back pain, a rigid and tender uterus, and tetanic (high-frequency, low-amplitude) contractions is classic for abruption, even in the absence of vaginal bleeding (which occurs in roughly 20% of cases). The maternal fibrinogen level of 190 mg/dL is dangerously low (normal pregnancy levels are 300-600 mg/dL) and indicates consumptive coagulopathy (DIC) triggered by the retroplacental clot. Simultaneously, the fetal tracing is Category III (absent variability with recurrent late decelerations), signifying severe hypoxia. The only definitive treatment to halt the coagulopathy and rescue the fetus is immediate operative delivery.

Adım Adım Çözüm

1
Analyze the maternal clinical and laboratory findings.
The patient has unremitting back pain, a firm and tender uterus, and high-frequency contractions without vaginal bleeding. Labs show a fibrinogen of 190 mg/dL (normal in pregnancy is >300 mg/dL).
These findings are highly suspicious for a concealed placental abruption leading to early disseminated intravascular coagulation (DIC).
2
Evaluate the fetal monitoring strip.
The tracing shows fetal tachycardia (165/min), absent variability, and recurrent late decelerations.
This constitutes a Category III fetal heart rate tracing, which indicates severe fetal hypoxia and acidemia.
3
Determine the definitive management.
Immediate surgical intervention is required.
The presence of a Category III tracing in the setting of an acute abruption and maternal coagulopathy mandates emergent cesarean delivery to prevent fetal demise and maternal exsanguination.

Anahtar Kavram

Concealed placental abruption can present without vaginal bleeding but with a rigid, tender uterus, tetanic contractions, and maternal coagulopathy (low fibrinogen). The definitive management in the presence of a Category III fetal heart rate tracing is immediate cesarean delivery.
Soru 679Soru →

A 7272-year-old woman, gravida 22, para 22, comes to the gynecologist reporting a vulvar lesion that she first noticed 44 months ago. She states that the area is occasionally pruritic and bleeds slightly when wiped. Her past medical history is notable for lichen sclerosus, which was diagnosed 1010 years ago and is managed with intermittent topical clobetasol. Menopause occurred at age 5151. On physical examination, the vagina and cervix appear atrophic. On the right labium majus, approximately 44 cm lateral to the midline, there is a 2.52.5 cm, firm, ulcerated, unifocal nodule. There are no palpable inguinal lymph nodes. A punch biopsy of the nodule confirms invasive squamous cell carcinoma with a depth of invasion of 3.53.5 mm. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Radical local excision with right inguinofemoral lymph node evaluation

Cevap

Radical local excision with right inguinofemoral lymph node evaluation
For early-stage invasive squamous cell carcinoma of the vulva, management is dictated by the size, depth of invasion, and location of the lesion. This patient has a Stage IB tumor because the depth of invasion (3.53.5 mm) exceeds 1.01.0 mm and the size (2.52.5 cm) exceeds 22 cm. Any vulvar cancer with >1> 1 mm depth of invasion requires inguinofemoral lymph node evaluation due to the risk of lymphatic metastasis. Because her lesion is clearly lateral (located 44 cm from the midline on the right labium majus), lymphatic drainage is predominantly unilateral. Therefore, radical local excision of the primary tumor combined with an ipsilateral (right) inguinofemoral lymph node evaluation (via complete dissection or sentinel lymph node biopsy) is the most appropriate next step.

Adım Adım Çözüm

1
Determine the stage of the vulvar cancer based on biopsy and physical examination findings.
The tumor is 2.52.5 cm in size with a depth of invasion of 3.53.5 mm.
Tumor size >2> 2 cm and depth >1> 1 mm classifies this as Stage IB vulvar carcinoma, which carries a substantial risk of lymphatic metastasis.
2
Identify the anatomic location of the lesion relative to the midline.
The lesion is unifocal and located on the right labium majus, 44 cm lateral to the midline.
Lesions situated >2> 2 cm from the midline are classified as lateral and primarily drain to the ipsilateral inguinofemoral lymph nodes, whereas midline lesions drain bilaterally.
3
Select the appropriate surgical intervention based on staging and anatomic location.
Radical local excision of the primary tumor combined with an ipsilateral (right) inguinofemoral lymph node evaluation.
The standard of care for lateral Stage IB vulvar cancer is wide excision with ipsilateral node assessment to evaluate for metastasis while avoiding the morbidity of unnecessary bilateral dissection.

Anahtar Kavram

Management of early-stage invasive vulvar cancer requires radical local excision. The need for lymph node evaluation depends on the depth of invasion (>1> 1 mm requires assessment), and the laterality of the evaluation (ipsilateral vs. bilateral) depends on the tumor's distance from the midline (lateral lesions ≥2\ge 2 cm from the midline require only ipsilateral dissection).
Tahmini Süre:1m 30s
Soru 680Soru →

A 58-year-old woman presents to the clinic with a 3-week history of continuous, thin, watery vaginal discharge that occasionally leaves pink stains on her undergarments. She reached menopause at age 51. Her medical history is notable for estrogen receptor-positive breast cancer diagnosed 4 years ago, which was treated with a lumpectomy and radiation therapy. She has been taking anastrozole for the past 3 years. Since starting the medication, she reports significant vaginal dryness and dyspareunia. Her vital signs are within normal limits. Speculum examination reveals pale, thin, and dry vaginal mucosa with a loss of rugation. There are no lacerations in the vaginal vault, but a small amount of dark red fluid is noted pooling at the external cervical os. Bimanual examination demonstrates a small, mobile, non-tender uterus without adnexal masses. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Endometrial biopsy

Cevap

Endometrial biopsy
Any vaginal bleeding in a postmenopausal woman must be evaluated to rule out endometrial carcinoma. This holds true even if the bleeding is merely described as a pink-tinged discharge or if blood is incidentally found at the cervical os. The standard initial diagnostic step is either an endometrial biopsy or a transvaginal ultrasound (which must show an endometrial stripe ≤ 4 mm to safely exclude malignancy). In this patient, the use of anastrozole has led to profound estrogen deficiency, causing the visible signs of genitourinary syndrome of menopause (atrophic vaginitis). While atrophic vaginitis is the most common cause of postmenopausal bleeding, a clinician cannot safely attribute the bleeding to this benign condition without first strictly excluding malignancy. Because transvaginal ultrasound is not an option here, an endometrial biopsy is explicitly indicated as the next best step.

Adım Adım Çözüm

1
Identify the primary clinical presentation.
The patient has a pink-tinged vaginal discharge and dark red fluid pooling at the cervical os, which functionally constitutes postmenopausal bleeding (PMB).
Any spotting, bleeding, or blood-tinged discharge in a postmenopausal woman is abnormal and requires formal oncologic evaluation.
2
Analyze the impact of the patient's medical history.
The use of anastrozole (an aromatase inhibitor) causes profound estrogen depletion, resulting in her severe genitourinary syndrome of menopause (atrophic vaginitis).
Recognizing the cause of her vaginal dryness explains a potential benign source of bleeding, acting as a cognitive distractor.
3
Apply the standard diagnostic algorithm for postmenopausal bleeding.
Despite having a highly plausible benign etiology for the bleeding (vaginal atrophy), clinical guidelines mandate ruling out endometrial carcinoma using either an endometrial biopsy or a transvaginal ultrasound.
Endometrial cancer must be formally excluded before attributing PMB to atrophy.
4
Select the correct intervention from the given options.
Because transvaginal ultrasound is not listed as an option (only the inadequate transabdominal route is present), direct tissue sampling via an endometrial biopsy is the definitive next step.
Endometrial biopsy directly assesses for the presence of hyperplasia or carcinoma.

Anahtar Kavram

All instances of postmenopausal bleeding must be evaluated with either an endometrial biopsy or a transvaginal ultrasound to rule out endometrial carcinoma, even when an obvious benign etiology like atrophic vaginitis is present.

Alternatif Yöntem

If transvaginal ultrasound (TVUS) had been an available option, it would also be considered a correct first step. An endometrial stripe thickness of ≤ 4 mm on TVUS has a highly negative predictive value for endometrial cancer, which would allow the clinician to safely proceed with treating the vaginal atrophy.
Tahmini Süre:1m 15s
ÖncekiSayfa 34 / 53Sonraki
Obstetrics and Gynecology Alıştırma Soruları — USMLE Step 2 CK — Sayfa 34 | Examkin